Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance
- PMID: 25973925
- PMCID: PMC4431726
- DOI: 10.1371/journal.pone.0125784
Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance
Abstract
Background: Cognitive deficits are observed throughout all developmental phases of psychosis. However, prior studies have usually focused on a limited illness period and used a wide variety of cognitive instruments. Therefore, it has been difficult to characterize or highlight cognitive functioning in different stages of psychosis.
Method: We administered the RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) tests to 4 participant subgroups, including healthy volunteers (controls, HC, n = 28), subjects at high risk for clinical psychosis (prodrome, CHR, n = 27), first-episode schizophrenia patients (FE-Sz, n = 26), and mid-term and long-term chronic schizophrenia patients (Ch-Sz, n =147). Comparison, correlation, and regression analyses of RBANS index scores were assessed among groups. We examined clinical outcomes over 2 years between the CHR and HC subjects, and RBANS domains were used as possible predictors for conversion to psychosis.
Results: Performance on all RBANS domains was significantly impaired during a post-onset stage of psychosis (FE-Sz and Ch-Sz), and RBANS scores declined along with disease progression. Regression analyses showed that for CHR and HC subjects, baseline impairment in delayed memory (DM) significantly predicted conversion to psychosis. Additionally, partial correlations showed that for FE-Sz and Ch-Sz subjects, DM was the only correlate with a later stage of psychosis.
Conclusions: Cognitive deficits broadly emerged, and diminished functioning followed along with disease progression. Impairment in DM is perhaps one domain that helps us understand the development of psychosis. A critical need is to monitor and treat memory functioning for psychotic patients throughout all phases of the disease.
Conflict of interest statement
Figures


Similar articles
-
From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.J Psychiatr Res. 2018 Jan;96:231-238. doi: 10.1016/j.jpsychires.2017.10.014. Epub 2017 Oct 19. J Psychiatr Res. 2018. PMID: 29121595 Free PMC article. Clinical Trial.
-
Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia.Psychiatry Res. 2018 May;263:147-153. doi: 10.1016/j.psychres.2018.02.054. Epub 2018 Mar 6. Psychiatry Res. 2018. PMID: 29554544
-
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.Arch Gen Psychiatry. 2010 Jun;67(6):578-88. doi: 10.1001/archgenpsychiatry.2010.66. Arch Gen Psychiatry. 2010. PMID: 20530007 Free PMC article.
-
[Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Encephale. 2013. PMID: 23528322 Review. French.
-
Memory Impairments and Psychosis Prediction: A Scoping Review and Theoretical Overview.Neuropsychol Rev. 2020 Dec;30(4):521-545. doi: 10.1007/s11065-020-09464-2. Epub 2020 Nov 23. Neuropsychol Rev. 2020. PMID: 33226539
Cited by
-
Functional connectivity abnormalities in Type I Chiari: associations with cognition and pain.Brain Commun. 2021 Jun 14;3(3):fcab137. doi: 10.1093/braincomms/fcab137. eCollection 2021 Jul. Brain Commun. 2021. PMID: 34278303 Free PMC article.
-
Neurocognitive resilience as a predictor of psychosis onset and functional outcomes in individuals at high risk.BMC Med. 2025 Apr 24;23(1):240. doi: 10.1186/s12916-025-04059-1. BMC Med. 2025. PMID: 40275324 Free PMC article.
-
Recall and recognition subtests of the repeatable battery for the assessment of neuropsychological status and their relationship to biomarkers of Alzheimer's disease.Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023 Sep-Nov;30(6):885-902. doi: 10.1080/13825585.2022.2124229. Epub 2022 Sep 15. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2023. PMID: 36110031 Free PMC article.
-
Comparing the Self-Reported Personality Disorder Traits and Childhood Traumatic Experiences Between Patients With Schizophrenia Vs. Major Depressive Disorder.Front Psychiatry. 2021 Oct 4;12:754174. doi: 10.3389/fpsyt.2021.754174. eCollection 2021. Front Psychiatry. 2021. PMID: 34671281 Free PMC article.
-
From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline.J Psychiatr Res. 2018 Jan;96:231-238. doi: 10.1016/j.jpsychires.2017.10.014. Epub 2017 Oct 19. J Psychiatr Res. 2018. PMID: 29121595 Free PMC article. Clinical Trial.
References
-
- Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000;26(1):119–36. Epub 2001/02/07. . - PubMed
-
- Sigaudo M, Crivelli B, Castagna F, Giugiario M, Mingrone C, Montemagni C, et al. Quality of life in stable schizophrenia: The relative contributions of disorganization and cognitive dysfunction. Schizophr Res. 2014;153(1–3):196–203. Epub 2014/02/04. doi: S0920-9964(14)00016-4 [pii] 10.1016/j.schres.2014.01.013 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical